<p>Number of annual cases among the 123,153 identified pulmonary tuberculosis (TB) cases and percentages of patients living with human immunodeficiency virus (HIV) in all age groups and in those aged between 15 and 49 years (upper panel), and percentages of patients aged between 15 and 49 years and those receiving combination antiretroviral therapy (cART) during anti-TB treatment among all patients with TB–HIV coinfection (lower panel).</p
Prevalence of TB/HIV co-infection, across age categories, for female adolescents and young women tre...
Tuberculosis is the top agenda among opportunistic diseases and the most leading cause of death in H...
Objective To assess the prevalence, treatment outcomes and determinants of tuberculosis (TB)–HIV coi...
Proportion of younger adolescents, older adolescents and young adults with TB/HIV coinfection on ART...
<p>Upper- and lower-bound estimates of tuberculosis incidence among adults aged 15–64 years with (so...
Prevalence of TB/HIV co-infection, across age categories, for male adolescents and young men treated...
<p>The numbers of tuberculosis notifications of new and recurrent disease in patients with known HIV...
<p>The HIV and HIV/TB groups refer to individuals enrolled in ClinSurv HIV since 1999; and HIV/TB pa...
Comparison of the proportion of 0–14 years old TB cases detected that were bacteriologically confirm...
Background: The human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pandemic ...
Background: The impact of HIV infection on tuberculosis (TB) rates in Quebec has not been fully esta...
Age, gender and the distribution of TB monoinfection, HIV monoinfection and TB-HIV coinfection among...
BACKGROUND:Tuberculosis and HIV remain a public health problem in developed countries. The objective...
Knowledge of tuberculosis incidence and associated factors is required for the development and evalu...
Background: Tuberculosis (TB) incidence in Cameroon is high with 32% of adult TB patients, all forms...
Prevalence of TB/HIV co-infection, across age categories, for female adolescents and young women tre...
Tuberculosis is the top agenda among opportunistic diseases and the most leading cause of death in H...
Objective To assess the prevalence, treatment outcomes and determinants of tuberculosis (TB)–HIV coi...
Proportion of younger adolescents, older adolescents and young adults with TB/HIV coinfection on ART...
<p>Upper- and lower-bound estimates of tuberculosis incidence among adults aged 15–64 years with (so...
Prevalence of TB/HIV co-infection, across age categories, for male adolescents and young men treated...
<p>The numbers of tuberculosis notifications of new and recurrent disease in patients with known HIV...
<p>The HIV and HIV/TB groups refer to individuals enrolled in ClinSurv HIV since 1999; and HIV/TB pa...
Comparison of the proportion of 0–14 years old TB cases detected that were bacteriologically confirm...
Background: The human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) pandemic ...
Background: The impact of HIV infection on tuberculosis (TB) rates in Quebec has not been fully esta...
Age, gender and the distribution of TB monoinfection, HIV monoinfection and TB-HIV coinfection among...
BACKGROUND:Tuberculosis and HIV remain a public health problem in developed countries. The objective...
Knowledge of tuberculosis incidence and associated factors is required for the development and evalu...
Background: Tuberculosis (TB) incidence in Cameroon is high with 32% of adult TB patients, all forms...
Prevalence of TB/HIV co-infection, across age categories, for female adolescents and young women tre...
Tuberculosis is the top agenda among opportunistic diseases and the most leading cause of death in H...
Objective To assess the prevalence, treatment outcomes and determinants of tuberculosis (TB)–HIV coi...